NUMEN

THE NUMEN PLATFORM

The platform behind treatment-response prediction.

Working models are our starting point. We are developing that capability into a proprietary platform for therapy-specific models and individual response profiles.

Built to develop, evaluate and deliver.

THE PRODUCT LOGIC

One platform. Defined applications. Understandable answers.

  1. Platform

    The shared technology foundation for developing, evaluating and delivering response models.

  2. Models

    Applications built around a specific therapy, population and treatment outcome.

  3. Profiles

    The model output, presented as an individual estimate with confidence and context.

A RESEARCH USE

Begin with the decision, not the dashboard.

A development team wants to understand whether information available before treatment can help predict later response. NUMEN’s approach connects that question to a defined evaluation and a result the team can examine.

Illustrative research scenario

Which pre-treatment information helps predict later response?

  1. Define the decision

    Establish the response question and why the answer matters to the programme.

  2. Evaluate the model

    Compare the candidate approach with clinical information alone and test its performance on separate data.

  3. Explain the result

    Connect findings, uncertainty and evidence to the next research decision.

THE PLATFORM OUTPUT

A response estimate with context.

The response profile turns a therapy-specific model’s output into a clear view of expected response, confidence and treatment context.

Open each heading to explore what the profile is designed to explain.

In development

Individual response profile

Expected response

An estimate for a defined therapy and treatment outcome.

The profile connects a response estimate to a specific question: one therapy, one outcome and a defined time horizon.

Confidence in the estimate

Uncertainty and the strength of supporting evidence.

The estimate sits alongside information about uncertainty and the evidence behind the model, giving the reader a clearer basis for interpretation.

Treatment context

The population, time horizon and model behind the estimate.

Context explains where the model applies and which question its output is designed to answer.

Individual response profile · In development · Illustrative interface

RESEARCH AND PRODUCT

Research today. Product development with a longer horizon.

The first partner engagement is a focused research package. The broader product direction is a family of therapy-specific applications on the NUMEN platform.

The research package

A study-level report addressing an agreed question, with findings, uncertainty and a clear next evaluation step.

The response profile

An individual estimate for a defined therapy, brought together with the evidence and context needed to interpret it.

OUR FIRST STUDY & SCORE

Psychedelic therapies. Our first focus.

Our first study and initial response-score development focus on psychedelic therapies.

The first application is a starting point, not the limit of the platform.

NEXT DEVELOPMENT PRIORITIES

From working models to defined applications.

Our development priorities connect existing capability with new therapy-specific questions and practical research use.

  1. Build on existing capability

    Develop a reusable platform around working models and relevant analytical tools.

  2. Evaluate therapy-specific predictions

    Establish what each application adds beyond clinical information.

  3. Pilot a defined research use

    Work towards a partner application with a clear question, scope and interpretable output.

LONGER TERM

More than a snapshot.

Our longer-term ambition is to understand individual response across time. We aim to develop models that connect observations into a richer picture of change and support more informed decisions.

The individual remains more than the model.

COLLABORATE

Bring us the next response question.

Start with the decision your team needs to make. We will discuss the right research scope together.